Iwai K, Maeda H, Konno T
Cancer Res. 1984 May;44(5):2115-21.
Highly malignant rabbit tumor (VX-2) was implanted at the periphery of the liver in 63 rabbits. Selective delivery of the anticancer agent copoly(styrenemaleic acid) conjugated to neocarzinostatin (SMANCS), which was dissolved in an oil contrast medium (Lipiodol), was performed by injection via the proper hepatic artery. The anticancer effect was also evaluated by various parameters. By using low-kVp X-ray examination of the resected rabbit liver, Lipiodol was found to distribute throughout the entire liver arterial lumina and was retained there for about 24 hr, but disappeared from the normal liver arterial lumina gradually. However, Lipiodol was retained in the tumor tissue and vessels for at least 7 days, whereas it was undetectable in any other organs. A radioactive analogue of Lipiodol, a chloroiodinated fatty acid, was prepared by using [14C]linoleic acid. This analogue was used in the study of the distribution by low-kVp X-ray examination, Sudan III staining, and autoradiography. Lipiodol remained in the tumor vessels as well as the tumor cells. The use of the radioisotope yielded a quantitative profile of Lipiodol accumulation in tumor tissues; approximately 1000 times more at 15 min and 100 times more at 3 days after the injection than that of most other organs or plasma. Its major excretion route appeared to be through the bile and then the feces. The biological activity of SMANCS was also determined and was found to be significant in both tumor and liver even 7 days after injection. No activity was found in any other organ or tissue. The relatively high biological activity of SMANCS in the nontumorous liver adjacent to the tumor may be the result of continuous drug release from SMANCS-Lipiodol in the tumor tissue. By histological examination, massive tumor necrosis and infiltration of the inflammatory cells were found in the rabbits treated with SMANCS-Lipiodol. In the rabbits treated with Lipiodol alone, necrosis of the tumor was only minimal, and no infiltration of inflammatory cells was observed. Survival periods of the treated rabbits (n = 14) were significantly longer than those of controls (n = 10); 23.1 +/- 5.5 (S.D.) days versus 16.1 +/- 2.9 days (p less than 0.005), respectively, even though only one injection was used for this highly malignant tumor. Mean tumor size for both groups at laparotomy was 163.3 +/- 83.0 sq mm and 160.5 +/- 76.5 sq mm, respectively (not significant).(ABSTRACT TRUNCATED AT 400 WORDS)
将高恶性兔肿瘤(VX - 2)植入63只兔子的肝脏周边。通过经肝固有动脉注射,实现了与新制癌菌素(SMANCS)偶联的抗癌剂聚(苯乙烯 - 马来酸)(溶解于油性造影剂碘油中)的选择性递送。还通过各种参数评估了抗癌效果。通过对切除的兔肝脏进行低千伏X射线检查发现,碘油分布于整个肝动脉管腔并在那里保留约24小时,但随后逐渐从正常肝动脉管腔中消失。然而,碘油在肿瘤组织和血管中至少保留7天,而在其他任何器官中均未检测到。通过使用[14C]亚油酸制备了碘油的放射性类似物氯碘化脂肪酸。该类似物用于通过低千伏X射线检查、苏丹III染色和放射自显影研究其分布。碘油保留在肿瘤血管以及肿瘤细胞中。使用放射性同位素得出了碘油在肿瘤组织中积累的定量概况;注射后15分钟时在肿瘤组织中的积累量比大多数其他器官或血浆中多约1000倍,3天时多100倍。其主要排泄途径似乎是通过胆汁然后经粪便排出。还测定了SMANCS的生物活性,发现即使在注射后7天,其在肿瘤和肝脏中仍具有显著活性。在任何其他器官或组织中均未发现活性。SMANCS在肿瘤附近的非肿瘤性肝脏中相对较高的生物活性可能是由于SMANCS - 碘油在肿瘤组织中持续释放药物所致。通过组织学检查发现,接受SMANCS - 碘油治疗的兔子出现大量肿瘤坏死和炎性细胞浸润。仅接受碘油治疗的兔子中,肿瘤坏死仅为轻微,未观察到炎性细胞浸润。接受治疗的兔子(n = 14)的生存期明显长于对照组(n = 10);分别为23.1±5.5(标准差)天和16.1±2.9天(p<0.005),尽管对于这种高恶性肿瘤仅进行了一次注射。两组在剖腹手术时的平均肿瘤大小分别为163.3±83.0平方毫米和160.5±76.5平方毫米(无显著差异)。(摘要截取自400字)